Skip to content

Effectiveness and Safety of Dual Aortic Cannulation in Aortic Reconstructive Arch Surgery for Newborns and Infants: A Multicenter, Retrospective Cohort Study

Effectiveness and Safety of Dual Aortic Cannulation in Aortic Reconstructive Arch Surgery for Newborns and Infants: A Multicenter, Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114121
Enrollment
Unknown
Registered
2025-12-08
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic coarctation

Interventions

Dual Aortic Cannulation Group:None
Deep Hypothermic Circulatory Arrest Group:None
Selective Antegrade Cerebral Perfusion Group:None

Sponsors

West China Second University Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: (1) Age of 0 to 11+ months; (2) Aortic arch reconstruction under cardiopulmonary bypass;

Exclusion criteria

Exclusion criteria: (1) The intraoperative perfusion strategy records were missing, and the perfusion strategy could not be judged. (2) Preoperative neurological complications; (3) Previous cardiac surgery history.

Design outcomes

Primary

MeasureTime frame
the incidence of major adverse events during hospitalization;

Secondary

MeasureTime frame
Postoperative incidence of low cardiac output syndrome (LCOS);Peak lactate levels (mmol/L) at 24, 48, and 72 hours postoperatively;Maximum VIS (vasoactive-inotropic score) within 24, 48, and 72 hours postoperatively;Duration of postoperative inotropic support (days);Echocardiography on the first day after surgery LVEF (%) and LVEDVI (mL/m2);Lowest intraoperative NIRS values ??(%) in the brain and lumbar region within 24 hours postoperatively;Incidence of postoperative hepatic dysfunction;Respiratory function: PaO?/FiO? ratio 24, 48, and 72 hours after surgery;3)Postoperative incidence of major gastrointestinal complications;4)Postoperative incidence of multiple organ dysfunction syndrome (MODS)/failure;Intraoperative blood transfusion volume (mL/kg);2)Chest tube drainage output during the first 24 hours after surgery (mL/kg);Cardiac-related rehospitalization rates at 30 days, 1 year, and during long-term follow-up;2)Cardiac-related reoperation rates at 30 days, 1 year, and during long-term follow-up;Survival status due to cardiac reasons at 30 days, 1 year, and during long-term follow-up;Total operative time (min);Cardiopulmonary bypass (CPB) duration (min);Aortic cross-clamping time (min);Circulatory arrest duration (min)/ SACP time (min);Cerebral NIRS minimal intraoperative (%) ;Lumbar NIRS minimal intraoperative (%) ;Peak lactate level during CPB (mmol/L);Postoperative surgical complications including diaphragmatic paralysis, recurrent laryngeal nerve injury, chylothorax, deep wound infection, mediastinitis, pulmonary artery stenosis and bronchomalacia;Postoperative residual lesion score (RLS);Duration of mechanical ventilation (min);Intensive care unit (ICU) length of stay (days);Total length of stay in the hospital (days);Delayed sternal closure rate and closure delay time (days); Re-sternotomy rate and time to reoperation (days);Extracorporeal membrane oxygenation (ECMO) utilization rate and support duration (days);Unplanned reoperation rate during hospitali

Countries

China

Contacts

Public ContactShuhua Luo

West China Second University Hospital, Sichuan University

drshuhualuo@wchscu.cn+86 189 8060 6194

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026